| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |